Infant formula suppliers the A2 Milk Company and Wattle Health Australia have strengthened their regulatory position in the lucrative Chinese market.
A2 Milk’s application to continue selling its infant products has been approved by the China Food and Drug Administration (CFDA). Formula manufacturer Synlait Milk, which has been in partnership with A2 Milk since 2010, submitted the mandatory CFDA application in May.
All infant formula manufacturers must register brands and recipes with the CFDA for products to be imported into China from January 1, 2018.
Foreign manufacturers of infant formula products in China must also register the canning facility used to blend and pack the products.
As seen in Townsville Bulletin, September 29th 2017.